Publications by authors named "Harriet Mayanja-Kizza"

Acute coronary syndrome is the leading cause of death worldwide, with the highest rates occurring in low-income global regions. This is possibly due to increasing levels of urbanization, which are accompanied by changes in diet and lifestyle, the most common risk factors for coronary artery disease (CAD). Risk factors for CAD are divided into traditional and non-traditional risk factors.

View Article and Find Full Text PDF

(Mtb) exposure leads to a range of outcomes including clearance, latent TB infection (LTBI), and pulmonary tuberculosis (TB). Some heavily exposed individuals resist tuberculin skin test (TST) and interferon-gamma (IFNγ) release assay (IGRA) conversion (RSTR), which suggests that they employ IFNγ-independent mechanisms of Mtb control. Here, we compare monocyte epigenetic profiles of RSTR and LTBI from a Ugandan household contact cohort.

View Article and Find Full Text PDF
Article Synopsis
  • * RSTR exhibit a specific expansion of T cells, particularly T17 and regulatory T cell-like programs, which are more pronounced than in individuals with latent Mtb infections.
  • * The study links these T17 cell-like responses to a lower risk of developing active tuberculosis in South African adolescents, proposing that RSTR may have unique mechanisms to control Mtb following exposure.
View Article and Find Full Text PDF
Article Synopsis
  • Limited data exists on red blood cell (RBC) alloimmunization in cancer patients in sub-Saharan Africa, prompting a study at the Uganda Cancer Institute to assess its frequency among transfused patients.
  • The randomized trial involved 277 participants receiving either leucoreduced or non-leucoreduced blood transfusions, with no participants developing allo-antibodies after transfusion.
  • The findings suggest that RBC alloimmunization may not be a concern for cancer patients in SSA, indicating a need for further research into routine antibody screening in this population.
View Article and Find Full Text PDF

remains one of the deadliest infectious agents globally. Amidst efforts to control TB, long treatment duration, drug toxicity, and resistance underscore the need for novel therapeutic strategies. Despite advances in understanding the interplay between microbiome and disease in humans, the specific role of the microbiome in predicting disease susceptibility and discriminating infection status in tuberculosis still needs to be fully investigated.

View Article and Find Full Text PDF

Background: Mortality benefit of transfusion with leucoreduced whole blood has not been demonstrated in the sub-Saharan Africa (SSA). We compared mortality in patients with cancer transfused with leucoreduced and non-leucoreduced whole blood in a SSA setting.

Methods: An open-label randomized controlled trial was conducted at the Uganda Cancer Institute where participants were randomized in a 1:1 ratio into the leucoreduced and non-leucoreduced whole blood transfusion arms.

View Article and Find Full Text PDF

T cells are required for protective immunity against Mycobacterium tuberculosis. We recently described a cohort of Ugandan household contacts of tuberculosis cases who appear to "resist" M. tuberculosis infection (resisters; RSTRs) and showed that these individuals harbor IFN-γ-independent T cell responses to M.

View Article and Find Full Text PDF

Reductions in tuberculosis (TB) incidence require identification of individuals at high risk of developing active disease, such as those with recent () infection. Using a prospective household contact (HHC) study in Kampala, Uganda, we diagnosed new infection using both the tuberculin skin test (TST) and interferon-gamma release assay (IGRA). Our study aimed to determine if the TST adds additional value to the characterization of IGRA converters.

View Article and Find Full Text PDF

Antibody features vary with tuberculosis (TB) disease state. Whether clinical variables, such as age or sex, influence associations between Mycobacterium tuberculosis-specific antibody responses and disease state is not well explored. Here we profiled Mycobacterium tuberculosis-specific antibody responses in 140 TB-exposed South African individuals from the Adolescent Cohort Study.

View Article and Find Full Text PDF

Introduction: The heterogeneity of outcomes after (Mtb) exposure is a conundrum associated with millennia of host-pathogen co-evolution. We hypothesized that human myeloid cells contain genetically encoded, Mtb-specific responses that regulate critical steps in tuberculosis (TB) pathogenesis.

Methods: We mapped genome-wide expression quantitative trait loci (eQTLs) in Mtb-infected monocytes with RNAseq from 80 Ugandan household contacts of pulmonary TB cases to identify monocyte-specific, Mtb-dependent eQTLs and their association with cytokine expression and clinical resistance to tuberculin skin test (TST) and interferon-γ release assay (IGRA) conversion.

View Article and Find Full Text PDF

(Mtb) exposure leads to a range of outcomes including clearance, latent TB infection (LTBI), and pulmonary tuberculosis (TB). Some heavily exposed individuals resist tuberculin skin test (TST) and interferon gamma release assay (IGRA) conversion (RSTR), which suggests that they employ IFNγ-independent mechanisms of Mtb control. Here, we compare monocyte epigenetic profiles of RSTR and LTBI from a Ugandan household contact cohort.

View Article and Find Full Text PDF

Tuberculosis (TB), caused by (Mtb), remains a leading cause of pediatric morbidity and mortality. Young children are at high risk of TB following Mtb exposure, and this vulnerability is secondary to insufficient host immunity during early life. Our primary objective was to compare CD4+ and CD8+ T-cell production of proinflammatory cytokines IFN-gamma, IL-2, and TNF-alpha in response to six mycobacterial antigens and superantigen staphylococcal enterotoxin B (SEB) between Ugandan adults with confirmed TB (n = 41) and young Ugandan children with confirmed (n = 12) and unconfirmed TB (n = 41), as well as non-TB lower respiratory tract infection (n = 39).

View Article and Find Full Text PDF

Objective: To determine whether Mycobacterium tuberculosis (Mtb)-induced monocyte transcriptional responses differ in people with HIV (PWH) who do (RSTR) or do not (LTBI) resist tuberculin skin test/interferon-γ (IFN-γ) release assay (TST/IGRA) conversion after exposure.

Design: We compared ex-vivo Mtb-induced monocyte transcriptional responses in a Ugandan tuberculosis (TB) household contact study of RSTR and LTBI individuals among PWH.

Methods: Monocytes were isolated from peripheral blood mononuclear cells from 19 household contacts of pulmonary TB patients, and their transcriptional profiles were measured with RNA-Seq after a 6 h infection with Mtb (H37Rv) or media.

View Article and Find Full Text PDF

The heterogeneity of outcomes after (Mtb) exposure is a conundrum associated with millennia of host-pathogen co-evolution. We hypothesized that human myeloid cells contain genetically encoded, Mtb-specific responses that regulate critical steps in tuberculosis (TB) pathogenesis. We mapped genome-wide expression quantitative trait loci (eQTLs) in Mtb-infected monocytes with RNAseq from 80 Ugandan household contacts of pulmonary TB cases to identify monocyte-specific, Mtb-dependent eQTLs and their association with cytokine expression and clinical resistance to tuberculin skin test (TST) and interferon-γ release assay (IGRA) conversion.

View Article and Find Full Text PDF

Purpose: Acute leukemias are associated with substantial morbidity and mortality, particularly in the adult population. Despite an increasing burden of acute leukemia in developing countries, there are limited data on clinical outcomes and prognostic factors in this setting. In this study, we aimed to describe the clinical characteristics, survival, and prognostic factors of adults with acute leukemia at the Uganda Cancer Institute (UCI).

View Article and Find Full Text PDF

Background: To improve tuberculosis (TB) diagnosis, the World Health Organisation (WHO) has called for a non-sputum based triage test to focus TB testing on people with a high likelihood of having active pulmonary tuberculosis (TB). Various host or pathogen biomarker-based testing devices are in design stage and require validity assessment. Host biomarkers have shown promise to accurately rule out active TB, but further research is required to determine generalisability.

View Article and Find Full Text PDF
Article Synopsis
  • The study addresses the need for biomarkers to improve tuberculosis treatment monitoring and shorten treatment durations.
  • The researchers examined serum biomarkers in 53 active pulmonary TB patients to evaluate their ability to predict treatment response after 2 months.
  • They found significant differences in certain biomarkers and identified a bio-signature that accurately predicted treatment outcomes, highlighting potential for future clinical trials and monitoring tools.
View Article and Find Full Text PDF

Motivation: The identification of differentially expressed genes (DEGs) from transcriptomic datasets is a major avenue of research across diverse disciplines. However, current bioinformatic tools do not support covariance matrices in DEG modeling. Here, we introduce kimma (Kinship In Mixed Model Analysis), an open-source R package for flexible linear mixed effects modeling including covariates, weights, random effects, covariance matrices, and fit metrics.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers studied how some people's immune systems are better at fighting infections like tuberculosis (TB).
  • They found specific gene changes in immune cells called monocytes that are connected to this unique ability.
  • The study discovered new genes linked to this immunity, which had not been noticed in earlier studies that looked at genes as a whole.
View Article and Find Full Text PDF

Purpose: AIDS-related mortality declined markedly since the introduction of antiretroviral therapy (ART); however, cancer mortality in Africa was higher than its incidence in 2020. People living with HIV (PLWHIV) are at an increased risk of malignancy and death from malignancy compared with the general population. In Uganda, AIDS-defining malignancies (ADMs), including cervical cancer, Kaposi sarcoma, and non-Hodgkin lymphoma, are among the commonest malignancies.

View Article and Find Full Text PDF
Article Synopsis
  • Tuberculosis (TB) remains a significant global health issue, and existing genome-wide studies have not effectively identified genes linked to the genetic risk and severity of adult pulmonary TB.
  • This research conducted a genome-wide association study (GWAS) on TB severity in independent cohorts in Uganda, identifying three significant SNPs, particularly one on chromosome 5 (rs1848553), which correlates with meaningful reductions in disease severity.
  • The findings suggest that genetic factors, especially related to vascular biology and immune response, play a crucial role in TB severity, indicating potential pathways for better management of the disease.
View Article and Find Full Text PDF
Article Synopsis
  • A standardized method called possible poor treatment response (PPTR) was developed to assess efficacy endpoints in a trial comparing rifapentine-based regimens for treating pulmonary tuberculosis (TB).
  • The PPTR process involved defining specific triggers that required standardized evaluations, including gathering multiple sputum samples for microbiological testing.
  • In the study of 2,343 participants, 19.4% experienced PPTR events, predominantly microbiological, which helped differentiate outcomes and support unbiased assessments of treatment efficacy in TB trials.
View Article and Find Full Text PDF